A carregar...
Neurological safety of fingolimod: An updated review
Fingolimod (FTY) is the first oral medication approved for treatment of relapsing–remitting multiple sclerosis (RRMS). Its effectiveness and safety were confirmed in several phase III clinical trials, but proper evaluation of safety in the real patient population requires long‐term post‐marketing mo...
Na minha lista:
| Publicado no: | Clin Exp Neuroimmunol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575715/ https://ncbi.nlm.nih.gov/pubmed/28932291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen3.12397 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|